INM

InMed Pharmaceuticals Inc. Common Shares

1.30

USD

INM Earnings Reports

Positive Surprise Ratio

INM beat 2 of 7 last estimates.

29%

Next Report

Date of Next Report

Feb 10, 2026

Estimate for Q2 26 (Revenue/ EPS)

Implied change from Q1 26 (Revenue/ EPS)

Implied change from Q2 25 (Revenue/ EPS)

InMed Pharmaceuticals Inc. Common Shares earnings per share and revenue

On Nov 06, 2025, INM reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were InMed Pharmaceuticals Inc. Common Shares's earnings and revenue for the latest quarter Q1 2026?

For Q1 2026, InMed Pharmaceuticals Inc. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to InMed Pharmaceuticals Inc. Common Shares's Q1 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is InMed Pharmaceuticals Inc. Common Shares expected to report next?

The next earning report is scheduled for Feb 10, 2026.

What are the forecasts for InMed Pharmaceuticals Inc. Common Shares's next earnings report?

Based on -- analysts, InMed Pharmaceuticals Inc. Common Shares is expected to report EPS of -- and revenue of -- for Q2 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.